Ipamorelin Dosage Guide: How Much, How Often, and Common Mistakes

Ipamorelin at a glance:

• Drug class: Selective GH secretagogue (research peptide)
• Route: subcutaneous injection
• Typical frequency: 1-3 times daily in user protocols
• Half-life: approximately 2 hours

Most people who quit Ipamorelin do it during titration, and most of those quits trace to dosing decisions. Get the schedule right and the rest is much easier.

Standard Dosing Schedule for Ipamorelin

Not FDA-approved. No officially established human dosing.

The typical schedule for Ipamorelin is 1-3 times daily in user protocols via subcutaneous injection. Half-life of approximately 2 hours explains why this schedule works — the drug stays active long enough to support that interval.

Titration: Why Starting Low Matters

For this class of compound, gradual titration is the standard approach. The starting doses listed above are not therapeutic — they exist to let the body adapt and to reduce gastrointestinal symptoms .

A typical titration plan for Ipamorelin holds each dose step for at least four weeks before moving up. Faster titration is associated with more dropouts due to side effects.

Missed Doses

If a dose of Ipamorelin is missed: for daily schedules, the rule of thumb is to take it as soon as remembered if within a defined window, otherwise skip it and resume the regular schedule. The exact window depends on the half-life (approximately 2 hours) and the specific product label. Never double up to make up for a missed dose.

Dose Adjustments

Dose adjustments may be needed for the following:

• Significant weight loss or weight gain
• Side-effect intolerance at the current step
• Changes in renal or hepatic function
• Drug interactions (particularly relevant for any concurrent medications)

We cover the side-effect side of dose decisions in Ipamorelin side effects and the cost angle of dose escalation in Ipamorelin cost.

What the Trials Used

Published trial data for Ipamorelin comes primarily from: Raun et al. 1998, Eur J Endocrinol — selective GH-releasing properties in animals and early human work.

That data drives the labeled dosing range, which is what physicians prescribe by.

Special Populations

The dosing guidance above applies to general adult use. Special populations — pregnancy, pediatric, severe renal impairment, hepatic dysfunction, elderly with frailty — require individualized assessment that this page can't substitute for.

For Ipamorelin: the standard contraindications for this drug class apply.

Bottom Line

Dosing Ipamorelin is a long game. Get the titration right, hold steady, and adjust deliberately based on how your body responds.

Frequently Asked Questions

Related Reading

• Ipamorelin Explained: How It Works and Who It's For
• Ipamorelin Side Effects in 2026: Real Reports, Real Solutions
• Does Ipamorelin Really Work? An Evidence-Based Results Review
• The Real Ipamorelin Price Tag in 2026 — With and Without Insurance
• The Honest Guide to MK-677: What Patients and Doctors Actually Say
• Is MK-677 Safe? An Honest Look at the Side-Effect Profile

Sources

• Stanley TL et al. Effects of Tesamorelin on Visceral Fat in HIV-Infected Patients With Lipodystrophy. NEJM 2010;363:2425.
• Nass R et al. Effects of an Oral Ghrelin Mimetic on Body Composition in Healthy Older Adults. Annals of Internal Medicine 2008;149:601.
• Teichman SL et al. Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295. JCEM 2006;91:799.

This page is informational only and is not medical advice. We do not provide guidance for self-administration of compounds that are not FDA-approved.